Editorial: The influence of medications on neurocognition in bipolar disorder

Acta Psychiatrica Scandinavica

Volumn 120, Issue 6, 2009, Pages 414-415

  Vieta, Eduard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANXIOLYTIC AGENT; ARMODAFINIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; FOLIC ACID; GALANTAMINE; HYPNOTIC AGENT; LITHIUM; MEMANTINE; MIFEPRISTONE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; HYPNOTIC SEDATIVE AGENT;

ANTICHOLINERGIC EFFECT; BIPOLAR DISORDER; COGNITIVE DEFECT; COMPARATIVE STUDY; DISABILITY; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; EDITORIAL; EXTRAPYRAMIDAL SYMPTOM; GENETICS; MANIA; MENTAL DISEASE; MOOD DISORDER; NEUROPROTECTION; NEUROPSYCHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PUBLICATION; REMISSION; SAMPLE SIZE; SCIENTIFIC LITERATURE; SEDATION; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; COGNITION; EXECUTIVE FUNCTION; HUMAN; NEUROPSYCHOLOGICAL TEST; NOTE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHOLINERGIC ANTAGONISTS; COGNITION; EXECUTIVE FUNCTION; HUMANS; HYPNOTICS AND SEDATIVES; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGY, EDUCATIONAL; RECURRENCE; TREATMENT OUTCOME;

EID: 70449337823     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01503.x     Document Type: Editorial

References (28)

1. López-Muñoz F, Vieta E, Rubio G, García-García P, Alamo C. Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach. J Affect Disord 2006 92 : 161 170.
2. Suominen K, Mantere O, Valtonen H, Arvilommi P, Leppamaki S, Isometsa E. Gender differences in bipolar disorder type I and II. Acta Psychiatr Scand 2009 120 : 464 473.
3. Born C, Seitz NN, Grunze H et al. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology. Acta Psychiatr Scand 2009 120 : 474 480.
4. Goswami U, Sharma A, Varma A et al. The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand 2009 120 : 456 463.
5. Parker GB, Fletcher K. Is bipolar II depression phenotipically distinctive? Acta Psychiatr Scand 2009 120 : 446 455.
6. Behzadi AH, Omrani Z, Chalian M, Asadi S, Ghadiri M. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr Scand 2009 120 : 441 445.
7. Pacchiarotti I, Mazzarini L, Colom F et al. Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr Scand 2009 120 : 416 428.
8. Martínez-Arán A, Vieta E, Colom F et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000 69 : 2 18.
9. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004 161 : 262 270.
10. Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007 9 : 103 113.
11. Tabarés-Seisdedos R, Escámez T, Martínez- Giménez JA et al. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from Mediterranean Spain: a preliminary study. Neuroscience 2006 139 : 1289 1300.
12. Balanzá-Martínez V, Rubio C, Selva-Vera G et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev 2008 32 : 1426 1438.
13. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002 180 : 313 319.
14. Bonnín CM, Martínez-Arán A, Torrent C et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 2009 [Epub ahead of print]
15. Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004 6 : 224 232.
16. Torrent C, Martínez-Arán A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006 189 : 254 259.
17. Martinez-Aran A, Torrent C, Tabares-Seisdedos R et al. Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry 2008 69 : 233 239.
18. Sanchez-Moreno J, Martinez-Aran A, Colom F et al. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry 2009 70 : 1120 1127.
19. Martinez-Aran A, Scott J, Colom F et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry 2009 70 : 1017 1023.
20. Martínez-Arán A, Vieta E, Colom F et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 2005 74 : 295 302.
21. Goldberg JF. Adverse cognitive effects of psychotropic medications. In : Goldberg JF, Burdick KE, eds. Cognitive dysfunction in bipolar disorder: a guide for clinicians. Washington DC : American Psychiatric Publishing, 2008 : 137 158.
22. Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand 2008 118 : 373 381.
23. Fountoulakis KN, Vieta E, Bouras C et al. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int J Neuropsychopharmacol 2008 11 : 269 287.
24. Daban C, Martínez-Arán A, Torrent C et al. Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results. J Clin Psychopharmacol 2006 26 : 178 181.
25. Colom F, Vieta E, Martinez-Aran A et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003 60 : 402 407.
26. Colom F, Vieta E, Sánchez-Moreno J et al. Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 2009 194 : 260 265.
27. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 2008 32 : 675 692.
28. Rosa AR, Sánchez-Moreno J, Martínez-Aran A et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemol Ment Health 2007 3 : 5.